Influence of Liver Fibrosis on Highly Active Antiretroviral Therapy--Associated Hepatotoxicity in Patients with HIV and Hepatitis C Virus Coinfection

Abstract

HAART-associated hepatotoxicity correlates with liver histological stage in patients coinfected with HIV and HCV. There was no difference in hepatotoxicity risk for different antiretroviral therapies in patients with mild-to-moderate fibrosis.